BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mantovani A, Zusi C. PNPLA3 gene and kidney disease. Exploration of Medicine 2020;1:42-50. [DOI: 10.37349/emed.2020.00004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan Y, Wang Y, Feng H, Guo Z, Li X, Nie X, Zhao Y. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.025] [Reference Citation Analysis]
2 Miao H, Wu XQ, Wang YN, Chen DQ, Chen L, Vaziri ND, Zhuang S, Guo Y, Su W, Ma SX, Zhang HQ, Shang YQ, Yu XY, Zhao YL, Mao JR, Gao M, Zhang JH, Zhao J, Zhang Y, Zhang L, Zhao YY, Cao G. 1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway. Br J Pharmacol 2021. [PMID: 34625952 DOI: 10.1111/bph.15705] [Reference Citation Analysis]
3 Mantovani A, Dalbeni A, Beatrice G, Cappelli D, Gomez-peralta F. Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes. JCM 2022;11:968. [DOI: 10.3390/jcm11040968] [Reference Citation Analysis]
4 Truong E, Noureddin M. The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.008] [Reference Citation Analysis]
5 Yu X, Sun Q, Zhang Y, Zou L, Zhao Y. TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis. Front Pharmacol 2022;13:860588. [DOI: 10.3389/fphar.2022.860588] [Reference Citation Analysis]